Pitches · 8:00–9:30 AM PT
Moonrise Medical
Adam God, CEO · adam@moonrisemedical.com
Automated ultrasound imaging for peripheral artery disease and diabetic foot ulcers
Round
$2.5M Convertible Note @ $9M cap pre
Closed
1.6M
FDA milestone
Pre-sub
FDA timeline
6 months to submission
Other groups in round
KF Matheson, Providence Health Ventures, MedTech Angels
DD package
yes
Traction: Endorsements, LOIs
What they're looking for: Commercialization advisors, sales reps once commercial
Anuncia Medical
Elsa Chi Abruzzo, CEO · eabruzzo@anunciamedical.com
In Market CSF Management & Neurocritical Care therapeutic and monitoring devices for noninvasive at-home use
Round
Series A Preferred Round of $6M Priced Round @ $22M premoney
Closed
~$4M
FDA milestone
ReFlow Mini has FDA Breakthrough Device and 510(k) Clearance
FDA timeline
Next product FDA 510(k) expected by 2H 2026
Other groups in round
AoA, BAI, Xcellerant Ventures, Keiretsu, US Boston Capital, etc.
DD package
yes
Traction: Commercial, expect over $500K this year and >$3M 2026
What they're looking for: Always, looking for advisors, KOLs, sales reps, etc.
Cosm
, CEO · dsham@cosm.care